Finance

Lists
HLS:TSE
HLS Therapeutics Inc
CA$4.10
-0.97%
(-0.040) 1D
Oct 16, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for HLS...
Open
CA$4.19
High
CA$4.20
Low
CA$4.06
Mkt. cap
123.86M
Avg. vol.
82.47K
Volume
15.34K
52-wk high
CA$5.62
52-wk low
CA$3.56
EPS
-CA$0.39
Beta
0.51
Shares outstanding
30.94M
No. of employees
85
Open
CA$4.19
High
CA$4.20
Low
CA$4.06
Mkt. cap
123.86M
Avg. vol.
82.47K
Volume
15.34K
52-wk high
CA$5.62
52-wk low
CA$3.56
EPS
-CA$0.39
Beta
0.51
Shares outstanding
30.94M
No. of employees
85
News stories
From web sources and news partners
About HLS Therapeutics Inc
CEO-
Employees85
Founded2014
Headquarters-
SectorPharmaceutical industry
Websitehlstherapeutics.com
Last report
Aug 12, 2026
Fiscal period
Q2 2026
-$0.03 / -$0.08
+62.50%beat
Revenue / Est. (USD)
14.67M / 14.18M
+3.51%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
13.51M
15.20M
12.86M
14.67M
Cost of goods sold
3.81M
4.28M
4.19M
4.56M
Cost of revenue
3.81M
4.28M
4.19M
4.56M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.78M
5.21M
5.21M
5.45M
Operating expense
11.08M
10.68M
10.89M
11.27M
Total operating expenses
14.88M
14.96M
15.08M
15.83M
Operating income
-1.37M
237.00K
-2.22M
-1.16M
Other non operating income
-534.00K
-517.00K
-87.00K
-73.00K
EBT including unusual items
-3.94M
-1.98M
-2.30M
-1.01M
EBT excluding unusual items
-3.94M
-1.98M
-2.30M
-1.01M
Income tax expense
-17.00K
-647.00K
2.00K
13.00K
Effective tax rate
0.43%
32.64%
-0.09%
-1.29%
Other operating expenses
-
-
-
-
Net income
-3.92M
-1.34M
-2.30M
-1.02M
Net profit margin
-29.00%
-8.79%
-17.86%
-6.95%
Earnings per share
-0.12
-0.04
-0.07
-0.03
Interest and investment income
24.00K
18.00K
12.00K
4.00K
Interest expense
-2.44M
-897.00K
-801.00K
-748.00K
Net interest expenses
-2.42M
-879.00K
-789.00K
-744.00K
Depreciation and amortization charges
5.51M
5.46M
5.54M
5.53M
EBITDA
4.14M
5.18M
3.32M
4.37M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps